Results 111 to 120 of about 209 (167)
Where Is the ‘Oma’ in Multiple Myeloma? Origins and Limitations of some Myeloma‐Related Terminology
eJHaem, Volume 7, Issue 3, June 2026.ABSTRACT Background Multiple myeloma, often simply called ‘myeloma’, is a clonal plasma cell malignancy that constitutes about one‐tenth of all cancers managed by haematologists. Although the disease was first clearly described in the first half of the 19th century, it was only called multiple myeloma several decades later.
Jecko Thachil, David P. Steensma
wiley +1 more source
Reactive Infectious Mucocutaneous Eruption (RIME): An Australian Case Series
Australasian Journal of Dermatology, Volume 67, Issue 4, Page 241-246, June 2026.ABSTRACT Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative.
Hamish Moore +2 more
wiley +1 more source
BJU International, Volume 137, Issue 6, Page 1032-1039, June 2026.Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps +11 more
wiley +1 more source
Long‐term patient‐reported outcomes of open urorectal fistula repair after prostate cancer treatment
BJU International, Volume 137, Issue 6, Page 1067-1075, June 2026.Objectives To evaluate long‐term outcomes of open urorectal fistula (URF) repair, including URF recurrence, need for re‐intervention, and patient‐reported outcomes. Patients and Methods This retrospective study included men undergoing open URF repair between 2014 and 2024.
Max C. Wagner +7 more
wiley +1 more source
The FASEB Journal, Volume 40, Issue 10, 31 May 2026.Intravesical delivery of p21 mRNA‐loaded lipid nanoparticles (p21‐LNP) restores the tumor suppressor p21 in bladder cancer. Localized p21 expression directly induces cell cycle arrest, DNA damage and apoptosis, and ultimately inhibits orthotopic tumor growth with minimal systemic distribution and favorable safety.
Jie Zeng +3 more
wiley +1 more source
Overall Survival and Functional Results of Prostate-Sparing Cystectomy [PDF]
Purpose: To compare two matched groups of men with bladder transitional cell carcinoma (TCC) who underwent prostate-sparing cystectomy (PSC) or conventional radical cystoprostatectomy (CRC).
Ahadi, Babak +6 more
core